Covidien Surgical Device Sales Growth Of 10.5% Is Driven By Laparoscopy
This article was originally published in The Gray Sheet
Executive Summary
Newly independent medical technology firm Covidien's surgical device sales growth of 10.5% for the quarter ended June 29 was driven by demand for autosuture laparoscopic instruments in the United States and Europe, the company reported during its fiscal third-quarter earnings call Aug. 9